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Abstract 
 
Objective: It has been documented that heart transplantation in children is often 
complicated by arterial hypertension and increased arterial stiffness. Aim:  to use 
innovative multi-site photoplethysmography (MPPG) pulse measurement and 
analysis technology to assess arterial stiffness change in paediatric heart transplant 
recipients (HTR) in comparison with healthy control (HC) children.  
Approach: 20 heart transplant (median age 13.5 years old) (8 male) recipients were 
compared to an overall age- and gender-matched group of 161 healthy controls (11.6 
years old) (74 male). The peripheral pulse was recorded bilaterally using MPPG at 
the ear lobe, index finger and great toe sites, along with an ECG cardiac timing 
reference. Segmental pulse arrival times between peripheral sites (finger-ear, PATf-
e; toe-finger, PATt-f; toe-ear, PATt-e) were calculated as arterial stiffness measures, 
and differences between subject groups tested using multivariate analysis. 
Normalised ear, finger and toe pulse shapes were also studied and compared 
between groups. 
Main results: After correction for heart rate, and diastolic and mean blood pressures 
the HTR group was found to have significantly lower segmental PATt-e and PATt-f 
measures, with median values of 150 ms versus 172 ms in HC (p=0.02) and 104 ms 
(versus 118 ms in HC, p=0.01), respectively, and consistent with increased arterial 
stiffness in the patient group. The normalised ear, finger and toe sites showed only a 
mild elongation in each rise time for the transplant group. 
Significance: This study shows innovative and easy-to-do multi-site 
photoplethysmography gives further evidence for increased arterial stiffness in 
children who have undergone successful cardiac transplantation. 
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Introduction 
 
Heart transplantation is a main therapeutic option for children and adolescents 
suffering from cardiomyopathy or end-stage congenital heart disease. This procedure 
has been shown to bring significant improvement in life expectancy [1-2]. However, 
health and survival after transplantation is compromised by several factors, including 
rejection, infection, arterial hypertension, coronary artery disease, graft failure, and 
malignancies. In particular, arterial hypertension is very common in paediatric heart 
transplant recipients (HTR) with a prevalence of up to 46% at one year post-
transplantation [3]. The blood pressure elevation in these children has been 
characterised by systolic blood pressure (SBP) that is mainly elevated at night and 
diastolic blood pressure (DBP) elevated throughout the 24 hours [4]. 
 
The blood pressure elevation noted in this population is likely to be multi-factorial. 
Increased arterial stiffness is associated with increased cardiovascular risk factor in 
adults but specific therapies are lacking [5]. Arterial stiffness [6-7] has been often 
assessed by the pulse wave velocity (PWV) measurement performed using the 
SphygmoCor mechanical pulse technology [8-11]. A study from our group confirmed 
that PWV measured using the SphygmoCor device was increased in children post-
transplantation when compared to healthy controls [12]. 
 
The SphygmoCor system, however, has a number of important disadvantages when 
used in a clinical setting: it is relatively expensive; and requires a skilled operator to 
undertake tonometer pulse measurements. Photoplethysmography (PPG) [13] 
provides an alternative method for assessment of the pulse using simple optical 
sensor technology. It is relatively low-cost and is quick to perform as pulses from 
multiple body sites can easily be acquired simultaneously. Our group has already 
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demonstrated various clinical applications using multi-site photoplethysmography 
(MPPG) pulse measurement technology and published data utilising pulse arrival 
timing measures  from different peripheral body sites to assess cardiovascular 
ageing in normal adult populations [14-17], a pilot in heart transplant patients [18], 
peripheral arterial disease [19], chronic fatigue syndrome, [20] and cardiovascular 
function in systemic sclerosis [21]. The aim of this study was to assess arterial 
stiffness change in paediatric HTR in comparison with healthy children using MPPG 
technology. 
 
 
 
Methods 
 
Participants 
 
The study was approved by the County Durham and Darlington Local Research 
Ethics Committee (05/Q1002/73) and all participants provided written informed 
consent to participate from their parent or guardian. 
 
Paediatric transplant recipients were recruited from the heart transplant clinic at the 
Freeman Hospital, Newcastle upon Tyne, UK. Patients were excluded from the study 
if they were less than 6 years of age, were less than 6 months post-transplantation, 
had a pacemaker in situ, or had cardiac arrhythmias resulting in unreliable pulse 
wave analysis. Healthy control (HC) subjects were recruited into the study from local 
schools. Children who were less than 6 years of age, on beta-blocker or 
amphetamine medication, a body mass index greater than 30 kg/m2, who smoked 
cigarettes, or had had caffeine less than 3 hours before the start of their 
measurements, were excluded. 
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Demographic and other standard clinical variables were collected on the day of 
measurement: age, height and arm and body segment lengths, weight, body mass 
index (BMI), and heart rate (HR). Blood pressure was measured manually at the arm 
using the standard Korotkoff sound method to give the SBP and DBP, from which the 
mean arterial pressure (MAP i.e. DBP + ((SBP-DBP)/3)) and the pulse pressure (PP 
i.e. SBP- DBP) were determined. 
 
Pulse wave measurements 
 
HTR patients were studied in a temperature-controlled room in the hospital with a 
mean ambient temperature of 25 °C. Healthy controls were studied in a room within 
the school where the mean study ambient temperature was 25 °C. 
 
MPPG pulses were measured from both the HTR and healthy control participants at 
the right and left ear lobes, index finger pads and great toe pad sites whilst the 
subject lay comfortably supine on a measurement couch. The PPG probes (Artema 
75333-5 for finger and toe sites, and 75331-9 for ear site) were near infrared (950 
nm, with daylight filter) and measured pulses in the reflection mode. A single lead 
electrocardiogram (ECG) was simultaneously acquired to provide a cardiac timing 
reference for determining PATs. The physiological waveforms were captured for a 
period of 2.5 minutes to computer (at 2.5 kHz, 16 bit ADC resolution) by one of two 
operators (EJS and AK). PPG amplifier bandwidth was 0.15 to 20 Hz. 
 
Pulse wave analysis 
 
The MPPG pulse waveforms were analysed off-line using Matlab-based signal 
processing and visualization software (The Mathworks Inc.) to provide beat-to-beat 
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PAT from the R-wave of the ECG to the foot of each of the 6 PPG pulse waveforms 
from left and right ear lobe, index finger and great toe. The pulse waveforms were 
digitally low pass filtered (20 Hz) and the ECG low pass filtered (30 Hz) using zero 
phase filters before the beat-to-beat detection stage for ECG R wave / pulse foot 
landmark identification for each of the 6 body sites A stage of manual quality 
checking then facilitated the interpolation of the occasional noisy pulse, for example 
in the case of pulse shape distortion related to intermittent subject movement artefact 
[19]. ECG and/or MPPG pulse measurements from any participant that were of very 
poor quality throughout the recording were excluded from the study. 
 
Timing analysis: The ear pulse transit time (PATe), finger pulse transit time (PATf) 
and toe pulse transit time (PATt) were each calculated as the median value from 60 
consecutive heartbeats, separately for the right and left body sides. It is emphasized 
that the individual site transit times to the finger or the toe will include the pre-ejection 
period (PEP), and to eliminate potential differences due to varying PEP, the transit 
time difference between finger and ear (PATf-e), toe and ear (PATt-e), and toe and 
finger (PATt-f) were calculated to assess arterial stiffness indirectly, as noted in other 
studies [22-23] (figure 1).  
 
Shape analysis: The normalized pulse shape at each measurement site was 
calculated to allow us to qualitatively compare overall characteristics between the HC 
with HTR participants. The normalized pulse shape profiles were calculated using our 
previously published methods [24] by using cubic spline interpolation to normalize 
both the pulse height (0 to 1) and width (100 pulse width intervals) from 60 
consecutive good quality pulses, each overlaid, and an average (median) normalized 
shape profile determined for each site. 
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Statistical analysis 
 
Statistical analysis was performed using Minitab (version 17) and also SPSS 
Statistics (version 24, IBM) software. Data were summarised using median, lower 
(Q1) and upper (Q3) quartiles, written using the form: median (Q1 - Q3). Gender 
distribution differences between groups were tested using the Fisher’s exact test. 
Paired data differences, e.g. bilateral differences in PAT measure, were tested using 
the non-parametric Wilcoxon signed rank test. Differences in the clinical 
characteristics between the controls and the HTR patients were tested by utilising the 
non-parametric Mann-Whitney U test. Statistical differences in arterial stiffness 
measures between the healthy controls and the HTR patients were tested using a) 
univariate analysis utilising the Mann-Whitney U test, and then b) multivariate 
analysis utilising binary logistic regression (BLR) which corrected for any significant 
differences in the main clinical characteristics between groups. A p-value less than 
0.05 was considered to represent statistical significance. 
 
 
 
Results 
 
Twenty eight HTR patients were recruited and 20 of these were included in the 
analysis. The reasons for exclusion were: presence of a pacemaker (2), too early 
after transplant (1), incomplete data records or poor signal quality (5). Two hundred 
and fourteen healthy children were originally recruited and 161 were included in the 
analysis. The reasons for exclusion were: beta-blocker or amphetamine medication 
(2), BMI>30 kg/m2 (3), caffeine within 3 hours of measurements (5), smoke cigarettes 
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(4), less than 6 years of age when measured (2), incomplete data records (3), and/or 
very poor ECG / MPPG signal quality for at least one of the measurement sites (40 of 
which 25 included the ear measurement site). 
 
Clinical variables 
 
Demographic and clinical characteristics are summarised for the two groups in Table 
1. The HTR and the control groups were not statistically different for age and gender 
distribution. There were no significant differences between groups for height, and 
body and arm segment lengths or ratios. All children in the HTR group received 
cyclosprorin. The HTR group had significantly higher HR (p<0.001), DBP (p<0.01), 
and MAP (p<0.05) and therefore, these three parameters were subsequently 
adjusted for by using the BLR multivariate analysis. 
 
Segmental body site pulse arrival times 
 
The Wilcoxon signed rank test did not show any significant differences between the 
right and left side at any of the 3 (ear, finger, toe) segmental levels in healthy 
controls; hence, measurements from the two sides were averaged together. There 
was a small but significant difference between right – left ears of HTR patients of 
+5.3 ms (p<0.05). Summary statistics of pulse arrival time for the two groups are 
given in Table 2. There were significant differences in site PAT between subject 
groups for the toes but not the ears or fingers. The segmental difference values for 
PATt-e, PATt-f were significantly lower in the HTR group, with median (lower quartile 
– upper quartile) values of 150 (131-161) ms, versus 172 (156-188) ms for controls 
(p=0.02) and 104 (89-111) ms, versus 118 (109-126) ms for healthy controls, 
(p=0.01), respectively (figure 2). These differences remained statistically significant 
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after correcting for HR, DBP, and MAP (each at p<0.05). No significant difference 
was found for the PATf-e measure between groups.  
 
Normalised pulse shapes 
 
There were no overall differences in the normalised pulse shapes between the right 
and left ears, fingers or toes, and by combining the bilateral sides they were similar to 
the expected shape characteristics seen in adult subjects [24]. When normalised 
pulse shapes from HC and HTR groups were compared the rising edge appeared to 
be mildly elongated at each site for the transplant patient group (figure 3). 
 
 
 
Discussion and Summary 
 
The increased HR and DBP found in the HTR group are consistent with previous 
results in the literature [4, 12, 25-26]. Cardiac transplantation results in complete 
denervation depriving the heart of one of its major rate-regulating mechanisms. In 
normal subjects, resting HR is predominantly determined by vagal influences so that 
following cardiac denervation resting HR is higher than normal [25]. The cause(s) of 
the elevated DBP is not known but is likely to be multifactorial with calcineurin 
inhibitors and renal dysfunction recognised as important factors in this population. 
Results on blood pressure parameters from this study and also from Klinge et al. 
(2009) are consistent with what has been found by O’Sullivan et al. (2005) who 
showed increased DBP in paediatric HTR over the 24-hour period whereas SBP was 
elevated only at night. No significant difference in SBP was found in this study. 
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Other research groups have shown the feasibility of deriving PATs and other timing 
and shape measures from PPG [27-29]; however, its potential clinical use requires 
further investigation, mainly to clarify the effect of possible confounders [17, 30]. Foo 
et al. (2005) reported a mean toe-finger PAT of 100 ms in a group of 24 Caucasian 
children aged 5 to 12 years. This compares to a median value of 118 ms found in our 
study. Apart from the fact of using different statistics (mean versus median value), 
the healthy group assessed in the present study also included children older than 12 
years and this could explain the larger value as these subjects would be expected to 
be taller. 
 
Our study with MPPG has used segmental PAT differences (PATt-e and PATt-f) to 
overcome the confounding effect of the pre-ejection period. Segmental differences in 
PAT were clearly found between the healthy control and HTR subject groups and 
these differences were also statistically significant after adjustment for other clinical 
variables, i.e. DBP, MAP and HR. It is also interesting to note that this study showed 
significant differences to the normal population for the PAT to the toe site but not to 
the finger or ear sites. This may suggest that the arterial rigidity may be increased, at 
least in children, predominantly in the larger vessels (descending aorta) than the 
medium sized vessels such as the carotid and brachial arteries. This clearly requires 
further study. Furthermore, we have shown that the overall normalised pulse shapes 
in HTR are not grossly different to normal and with only apparent mild elongation in 
the rise time of the normalised shape pulses at the ear, finger and toe sites for the 
patient group. We have reported the triangulation and subtle elongation of pulse 
characteristics with age [24] and our further work will include a detailed comparison 
of pulse timing and shape characteristics between our adult cohort and this paediatric 
cohort to further explore aging and PPG waveforms. 
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Although it is not essential to measure the segmental limb lengths to get 
measurements of arterial stiffness, the MPPG technique, using segmental site timing 
comparisons, can be used to estimate the pulse wave velocity (PWV) if the 
appropriate lengths are measured [31]. In this study the PPG derived PWV was 
determined as a feasibility study in a subset of 11 of the HTR patients where reliable 
body segment length measurements were available and allowing comparisons with 
the healthy control group. As may have been expected, the PWV from the subset 
was significantly higher in the HTR group (6.0 m/s versus 5.3 m/s for controls; 
p<0.001, unpublished data). This is in keeping with the study by Klinge et al. (2009) 
where the adjusted aortic PWV was 5.3 m/s for HTR patients and 4.7 m/s for healthy 
children obtained using the SphygmoCor device. PWV data in children are relatively 
uncommon in the literature and the data available is further complicated by the fact 
that different anatomical sites and different technologies have been used. Some 
authors used PWV values from proximal sites such as differences between ear and 
finger [15] and others PWV from finger and toe site differences [30]. Foo et al. 
studied in an Asian population a group of 55 children, 39 males and 16 females, 
aged 5 to 12 years old, and reported a mean PWV of 7.3 m/s. 
 
The causes of the abnormal blood pressure in children following heart transplantation 
requires further study. Increased rigidity of the arterial system in elderly patients is 
characterised by higher SBP and lower DBP, hence a larger pulse pressure [32-33]. 
This is not the pattern observed in children following heart transplant and it is likely 
therefore that increased rigidity is not the complete explanation. A combination of 
factors including increased rigidity, denervation, renal dysfunction, and calcineurin 
inhibitors must be considered in investigating pathophysiology. The optimal drug 
therapy is, likewise, not known and it is possible that the therapeutic effects on 
arterial stiffness, as well as blood pressure, should be routinely measured when 
assessing response to drug therapy. Furthermore, Dall et al. (2015) [34] and 
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Passcualino et al. (2015) [35] both showed that a programme of exercise therapy did 
not reduce the arterial stiffness in HTR. The clinical acceptability and feasibility of our 
multi-site photoplethysmography technique means that this could be considered as 
part of sequential assessment of the vascular system in heart transplantation 
cardiovascular research. We also believe that our unique pulse data sets from both 
healthy children and those having had a heart transplant will contain valuable 
information regarding autonomic function and endothelial function – these aspects 
are being explored by the team and to be reported on [36-37]. 
 
Limitations of the study: We recognise that, although unlikely, the delays seen in 
HTR might result from the actual surgery and subsequent possible scarring of tissue, 
there was however no evidence of pulse damping overall for the HTR group; 
although we did not measure the sympathetic tone at the legs as this could be a 
source of vasoconstriction and pulse delay, however although the PPG “DC” low 
frequency changes for PPG at the toes did not reflect such activity in this study we 
will explore further the signal variability aspect for the two subject groups and we aim 
to report this in a subsequent publication.  
 
In summary, this study has shown that significantly increased arterial stiffness in 
children who have successfully undergone cardiac transplantation has been 
measured using our simple multi-site photoplethysmography technology, 
demonstrating that the technology  can provide relatively rapid and reliable 
assessment of arterial stiffness changes in this population. The assessment of 
arterial stiffness in these patients would be beneficial to target appropriate blood 
pressure management and inform the choice of specific medication and therapy for 
individual patients.  
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Legends 
 
Figure 1. Example of individual body site pulse transit time (PATe, PATf, and PATt) 
and their segmental timing difference computation (PATf-e, finger site – ear site; 
PATt-f, toe – finger; PATt-e, toe - ear). PAT values are calculated using the median 
of 60 consecutive pulses. 
 
Figure 2. Significantly reduced segmental pulse arrival times in the HTR group for 
toe-ear (PATt-e)  and  toe-finger site (PATt-f) segmental timing differences (each 
p<0.005 without BLR correction; p<0.05 with BLR correction for heart rate, diastolic 
and mean arterial blood pressures). No significant difference was found for the PATf-
e measure between groups. The boxplots represent the median (with symbol), IQR 
and also the 10-90 percentile values. 
 
Figure 3. Normalised shape profiles for HC and HTR ear, finger and toe sites. 
Diagrammatically, there was an overall tendency for mild elongation of the pulse rise 
time for each site with the transplant patients - as illustrated by the clear early peaks 
in each HTR-HC difference plot. 
 
Table 1. Summary of the clinical characteristics for the two participant groups. The p-
value for the gender difference is from the Fisher’s exact test; in all other cases the 
Mann-Whitney U-test was used. NS indicates not statistically significant. 
 
Table 2. Multi-site photoplethysmography pulse arrival times for the ear lobe, index 
finger and great toe sites, and their segmental timing differences. The segmental 
pulse timing differences between finger and toe and between ear and toe sites were 
statistically significant between the participant groups. The p-values were from the 
Mann-Whitney U-test. NS indicates not-significant statistically.  
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Table 1. 
 
 
 
 
Healthy Controls 
(HC) 
 
Median (Q1 - Q3) 
 
 
Heart Transplant 
Recipients (HTR)  
 
Median (Q1 - Q3) 
 
 
HC vs HTR  
(p-value) 
 
Subjects (males) 161 (74) 20 (8) NS 
Age  
(years) 11.6 (9.2 - 13.3) 13.5 (8.5 - 16.5) NS 
Height  
(m) 1.45 (1.35 - 1.58) 1.49 (1.26 - 1.60) NS 
Weight  
(kg) 40.0 (29.0 - 51.5) 40.0 (25.2 - 54.5) NS 
BMI  
(kg/m2) 18.3 (15.5 - 20.5) 16.7 (15.2 - 21.0) NS 
Heart Rate  
(beats per minute) 78 (72 - 83) 93 (79 - 99) < 0.001 
SBP  
(mmHg) 105 (98-116) 109 (101 - 120) NS 
DBP  
(mmHg) 62 (54 - 71) 73 (59 - 80) < 0.01 
MAP  
(mmHg) 77 (70 - 85) 87 (70 - 93) < 0.05 
PP  
(mmHg) 44 (34 - 51) 38 (30 - 50) NS 
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Table 2.  
 
Pulse timing 
measure  
 
Healthy Controls 
(HC) 
 
Median (Q1 - Q3) 
(ms) 
 
Heart Transplant 
Recipients (HTR) 
 
Median (Q1 - Q3) 
(ms) 
HC vs HTR 
(p-value) 
Ear PAT 136 (129 - 147) 139 (137 - 153) NS 
Finger PAT 191 (175 - 204) 189 (179 - 201) NS 
Toe PAT 311 (290 - 324) 292 (271 - 303) p = 0.006 
 
  
 
PATf-e 54 (44 – 62) 48 (40 – 56) NS 
PATt-f 118 (109 - 126) 104 (89 - 111) p <0.001 
PATt-e 172 (156 - 188) 150 (131 - 161) p <0.005 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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